NEW YORK (Reuters Health) – A selective with antiprogestin effects, CDB-2914, reduces uterine fibroid size and bleeding, and improves quality of life in affected women, according to a…
NEW YORK (Reuters Health) – After endoscopic balloon dilation of intestinal strictures in children with Crohn’s disease, an intralesional injection of triamcinolone reduces the rate of recurrence, according…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 2. Our second daily wrap-up features highlights from the key late breaking trials, and some…
NEW YORK (Reuters Health) – Almost a quarter of overweight women and nearly a half of overweight men in the US think there’s nothing wrong with their weight.…
NEW YORK (Reuters Health) – Following endoscopic sphincterotomy, large bile duct stones can be managed as successfully with large balloon dilation as with traditional mechanical lithotripsy, and with…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that antenatal steroids seem safe and reduce adverse outcomes in preterm infants when the pregnancy is complicated by…
Join us for Meetings in Minutes – AHA Scientific Sessions 2010 – Day 1. Our first day wrap-up features highlights from the presidential address, the key late breaking…
Did you miss AMA’s 2010 Interim Meeting of the House of Delegates? Don’t worry, The Doctor’s Channel has you covered. Get all of the highlights from the meeting…
NEW YORK (Reuters Health) – Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized…
NEW YORK (Reuters Health) – White matter (WM) hyperintensities seen on MRI brain scans correlate with gait and stability difficulties in elderly subjects, as well as with reduced…
NEW YORK (Reuters Health) – Patients who begin dialysis when kidney disease is at a relatively early stage have an increased risk of dying in the following year,…
The Doctor’s Channel is on location in Chicago at the American Heart Association Scientific Sessions 2010. We will be bringing you need-to-know information on late breaking trials, scientific…